Home » Topics » Regulatory » Patents

Patents
RSS

SmithKline Beecham reports novel hemoregulatory compounds

July 8, 1997

Novartis discovers compounds with anti-PDE IV and other actions

July 8, 1997

AHP discloses agents useful for disorders of the dopaminergic system

July 8, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

MMP/TNF-alpha inhibitors from Abbott

July 7, 1997

HIV protease inhibitors described by Searle

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Selective dopamine autoreceptor agonists prepared by American Home Products

July 7, 1997

Antimalarial agents from Roche

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.